Clinical Trials Directory

Trials / Completed

CompletedNCT03272061

Exercise and Brain Vascular Function

The Effects of Aerobic-based Exercise on Brain Vascular Function in Elderly Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
Male
Age
60 Years – 70 Years
Healthy volunteers
Accepted

Summary

Cognitive performance is negatively related to an impaired glucose metabolism, possibly due to impairments in brain vascular function. Supported by the statement from the American Heart and Stroke Association that physical exercise is one of the most effective strategies to protect against cognitive decline, we now hypothesize that exercise-induced changes in glucose metabolism cause beneficial effects on brain vascular function thereby improving cognitive performance. The primary objective of this intervention study is thus to evaluate in sedentary elderly men the effect of a 8-week aerobic-based exercise program on cerebral blood flow, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI) perfusion method Arterial Spin Labeling (ASL). Cerebral blood flow is a robust and sensitive physiological marker of brain vascular function. Secondary objectives are to examine effects on glucose metabolism using the oral glucose tolerance test and cognitive performance as assessed with a neurophysiological test battery.

Conditions

Interventions

TypeNameDescription
OTHERAerobic-based exercise programAerobic-based exercise will be carried out on a cycling ergometer three times a week for 30 minutes at 70% of the maximal workload. Every two weeks, the maximal workload will be reassessed, and training loads will be readjusted accordingly. Fully supervised training sessions will be performed with three-to-four study participants at a time. Subjects should maintain their body weight during the intervention period.

Timeline

Start date
2017-12-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2017-09-05
Last updated
2019-01-16

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03272061. Inclusion in this directory is not an endorsement.